Format

Send to

Choose Destination
Epidemiol Infect. 2015 May;143(7):1333-51. doi: 10.1017/S0950268814002829. Epub 2014 Oct 30.

Systematic review and meta-analysis of the proportion of non-typhoidal Salmonella cases that develop chronic sequelae.

Author information

1
Centre for Public Health and Zoonoses,University of Guelph,Guelph,Ontario,Canada.
2
Centre for Food-borne,Environmental and Zoonotic Infectious Diseases,Public Health Agency of Canada,Guelph,Ontario,Canada.
3
Laboratory for Foodborne Zoonoses,Public Health Agency of Canada,Guelph,Ontario,Canada.

Abstract

The objective of this systematic review and meta-analysis was to estimate the proportion of cases of non-typhoidal salmonellosis (NTS) that develop chronic sequelae, and to investigate factors associated with heterogeneity. Articles published in English prior to July 2011 were identified by searching PubMed, Agricola, CabDirect, and Food Safety and Technology Abstracts. Observational studies reporting the number of NTS cases that developed reactive arthritis (ReA), Reiter's syndrome (RS), haemolytic uraemic syndrome (HUS), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) or Guillain-Barré syndrome (GBS), Miller-Fisher syndrome (MFS) were included. Meta-analysis was performed using random effects and heterogeneity was assessed using the I 2 value. Meta-regression was used to explore the influence of study-level variables on heterogeneity. A total of 32 studies were identified; 25 reported on ReA, five reported on RS, seven reported on IBS, two reported on IBD, two reported on GBS, one reported on MFS, and two reported on HUS. There was insufficient data in the literature to calculate a pooled estimate for RS, HUS, IBD, GBS, or MFS. The pooled estimate of the proportion of cases of NTS that developed ReA and IBS had substantive heterogeneity, limiting the applicability of a single estimate. Thus, these estimates should be interpreted with caution and reasons for the high heterogeneity should be further explored.

KEYWORDS:

salmonellosis

PMID:
25354965
PMCID:
PMC4411645
DOI:
10.1017/S0950268814002829
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Cambridge University Press Icon for PubMed Central
Loading ...
Support Center